These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15853682)

  • 1. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system.
    Phinney DG; Isakova I
    Curr Pharm Des; 2005; 11(10):1255-65. PubMed ID: 15853682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials.
    Seo JH; Cho SR
    Yonsei Med J; 2012 Nov; 53(6):1059-67. PubMed ID: 23074102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection.
    Kassis I; Vaknin-Dembinsky A; Karussis D
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):63-8. PubMed ID: 20955154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?
    Kuroda Y; Kitada M; Wakao S; Dezawa M
    Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):369-78. PubMed ID: 21789625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders.
    Colpo GD; Ascoli BM; Wollenhaupt-Aguiar B; Pfaffenseller B; Silva EG; Cirne-Lima EO; Quevedo J; Kapczinski F; Rosa AR
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1435-49. PubMed ID: 26247151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment.
    Alexanian AR; Maiman DJ; Kurpad SN; Gennarelli TA
    Stem Cells Dev; 2008 Dec; 17(6):1123-30. PubMed ID: 18484898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells as cellular vectors for pediatric neurological disorders.
    Phinney DG; Isakova IA
    Brain Res; 2014 Jul; 1573():92-107. PubMed ID: 24858930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking and differentiation of mesenchymal stem cells.
    Liu ZJ; Zhuge Y; Velazquez OC
    J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy.
    Phinney DG
    Cell Cycle; 2007 Dec; 6(23):2884-9. PubMed ID: 18000405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Trials With Mesenchymal Stem Cells: An Update.
    Squillaro T; Peluso G; Galderisi U
    Cell Transplant; 2016; 25(5):829-48. PubMed ID: 26423725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases.
    Gorabi AM; Kiaie N; Barreto GE; Read MI; Tafti HA; Sahebkar A
    Mol Neurobiol; 2019 Dec; 56(12):8157-8167. PubMed ID: 31197655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.
    Frausin S; Viventi S; Verga Falzacappa L; Quattromani MJ; Leanza G; Tommasini A; Valencic E
    Acta Histochem; 2015; 117(4-5):329-38. PubMed ID: 25747736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells: new approaches for the treatment of neurological diseases.
    Momin EN; Mohyeldin A; Zaidi HA; Vela G; Quiñones-Hinojosa A
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):326-44. PubMed ID: 20528757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.
    Choudhary P; Gupta A; Singh S
    J Mol Neurosci; 2021 May; 71(5):889-901. PubMed ID: 33047251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases.
    Lo Furno D; Mannino G; Giuffrida R
    J Cell Physiol; 2018 May; 233(5):3982-3999. PubMed ID: 28926091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Neurodegenerative Diseases.
    Yao P; Zhou L; Zhu L; Zhou B; Yu Q
    Eur Neurol; 2020; 83(3):235-241. PubMed ID: 32690856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells: potential in treatment of neurodegenerative diseases.
    Tanna T; Sachan V
    Curr Stem Cell Res Ther; 2014; 9(6):513-21. PubMed ID: 25248677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured rats.
    Alexanian AR; Fehlings MG; Zhang Z; Maiman DJ
    Neurorehabil Neural Repair; 2011; 25(9):873-80. PubMed ID: 21844281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.